Results 31 to 40 of about 35,648 (268)

Combating Cholera [version 1; peer review: 2 approved]

open access: yesF1000Research, 2019
Cholera infections caused by the gamma-proteobacterium Vibrio cholerae have ravaged human populations for centuries, and cholera pandemics have afflicted every corner of the globe.
Brian Y. Hsueh, Christopher M. Waters
doaj   +1 more source

Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus. [PDF]

open access: yesPLoS ONE, 2017
The use of whole cell killed (WCK) oral cholera vaccines is an important strategy for cholera prevention in endemic areas. To overcome current vaccine limitations, we engineered strains of V.
Caitlyn A Hauke, Ronald K Taylor
doaj   +1 more source

The influence of immunomodulators on the formation of vaccine-induced cholera immunity

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2022
Introduction. Due to the remaining tense situation on cholera in the world, research continues on the creation of new preventive drugs, as well as ways to increase the immunogenicity of existing anti-cholera vaccines.
A. V. Filippenko   +3 more
doaj   +1 more source

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges. [PDF]

open access: yes, 2019
Introduction: Tuberculosis (TB) remains a major health threat and it is now clear that the current vaccine, BCG, is unable to arrest the global TB epidemic. A new vaccine is needed to either replace or boost BCG so that a better level of protection could
Barclay WR   +8 more
core   +1 more source

Vaccination in emergencies. [PDF]

open access: yes, 1999
Nongovernmental organisations (NGOs) are the main actors of vaccine delivery during complex humanitarian emergencies such as large population displacements.
Paquet, C
core   +2 more sources

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

open access: yes, 2007
Vietnam currently produces an orally administered, bivalent (O1 and O139) killed whole-cell vaccine and is the only country in the world with endemic cholera to use an oral cholera vaccine in public health practice.
Anh, Dang Duc   +13 more
core   +1 more source

Urban Cholera transmission hotspots and their implications for Reactive Vaccination: evidence from Bissau city, Guinea Bissau [PDF]

open access: yes, 2012
Use of cholera vaccines in response to epidemics (reactive vaccination) may provide an effective supplement to traditional control measures. In Haiti, reactive vaccination was considered but, until recently, rejected in part due to limited global supply ...
Azman, A S   +7 more
core   +5 more sources

Advances in enteric disease vaccines: from innovation to implementation [PDF]

open access: yes, 2014
The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core   +1 more source

Vaccination strategies to combat an infectious globe: Oral cholera vaccines

open access: yesJournal of Global Infectious Diseases, 2011
Cholera is a substantial health burden in many countries in Africa and Asia, where it is endemic. It is as well responsible for ongoing epidemics in sub-Saharan Africa which are becoming greater in terms of frequency, extension, and duration.
Rosa M López-Gigosos   +3 more
doaj   +1 more source

Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. [PDF]

open access: yesPLoS ONE, 2014
There is increasing interest to use oral cholera vaccination as an additional strategy to water and sanitation interventions against endemic and epidemic cholera.
Jacqueline Deen   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy